INDUSTRY PIONEERS
Improving Lives with Precision Diagnostics®
Invivoscribe is a leader in precision diagnostics, with over 30 years of experience developing and manufacturing assays for leukemias and lymphomas. Our tests deliver clinically meaningful results that help guide and refine treatment decisions.
As pioneers of the world’s first approved AML CDx, Invivoscribe continues to drive precision diagnostics forward with CDx solutions approved for three drugs in key markets around the world.
INDUSTRY PIONEERS
Improving Lives with Precision Diagnostics®
Invivoscribe is a leader in precision diagnostics, with over 30 years of experience developing and manufacturing assays for leukemias and lymphomas. Our tests deliver clinically meaningful results that help guide and refine treatment decisions. As pioneers of the world’s first approved AML CDx, Invivoscribe continues to drive precision diagnostics forward with CDx solutions approved for three drugs in key markets around the world.
PRODUCTS
Best-in-Class Assays and Reagents
Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls. As a premier diagnostics products manufacturer, we only offer superior-quality products.
CLINICAL LAB SERVICES
LabPMM Offers Clinical Services with Global Reach
The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offers internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care. As experts in molecular diagnostics, we ensure accurate and efficient testing for patients worldwide.
